Introduction
Asymmetric hydrogenation that makes use of molecular hydrogen to reduce prochiral olefins, ketones, and imines has become one of the most efficient, practical and atom economical methods for the construction of chiral compounds. 1 During the latter decades of the 20 th century, considerable attention has been devotedto the discovery of asymmetric olefin hydrogenation by rhodium 2 and ruthenium-diphosphine 3 complexes. Both rhodium and ruthenium complexes need the presence of a coordinating functional group which is often an amide derivatives or an allylic alcohol that are typical substrate classes adjacent to the C=C double bond. This group, together with the olefinic double bond, chelate to the metal center to form a cyclic intermediate that governs the stereo chemical outcome of the hydrogenation reaction. 4 The application of rhodium or ruthenium based catalysts has thus been restricted to the effective asymmetric hydrogenation of olefinic substrates without coordinating groups or with less-coordinating groups. 5, 6 The first crucial outcomein the hydrogenation of unfunctionalized olefins appeared in literature in 1998 when Pflatz and co-workers unveiled a new class of chiral iridium N,P-ligand complexes that overcame the limitations of the rhodium and ruthenium based systems. 7 Additionally, iridium N,P-complexes showedremarkably high activity in the hydrogenation of unfunctionalized tri-and tetrasubstituted alkenes. These are the chiral analogue of the Crabtree catalyst, 8 [Ir(pyridine)(Cy 3 P)(COD)]PF 6 (Cy = cyclohexyl, COD = cyclooctadiene) that provided the reason for the this preliminary investigation. In addition, these iridium N,P-ligand based catalysts presentedfavorable results of asymmetric hydrogenation of various functionalized alkenes and imines.
Our research is focused on the development of new ligands for Ircatalyzed asymmetric hydrogenation of olefins and imines that display high activities and selectivities. 9 Iridium complexes of phosphine-oxazoline ligands derived from bicyclic proline (Scheme 1)such as 1 are highly effective catalysts for asymmetric hydrogenation of both olefins and imines. 10 It was discovered that the removal of the additional chiral center in complex 1 by replacement of the oxazoline with thiazole rings to produce complex 2, generated catalysts that continue to display high activities andenatioselectivities for asymmetric hydrogenation of various alkenes, especially trisubstituted ones. The Gilbertson group has synthesized a series of Ir-complexes 3 derived from proline-based phosphine-oxazoline ligand and has demonstrated their potential as catalysts for asymmetric hydrogenation of highly substituted olefins. 12 The objective of this study was to synthesize Ir-complexes of N,Pligands derived from L-proline and evaluate them as chiral catalysts for asymmetric hydrogenation of trisubstituted olefins.
Results and Discussion
Five proline-based N,P-ligand precursors were prepared from Cbz-L-proline as shown in Schemes 2 and 3. The benzothiazole ligand precursor (4a) was synthesized by amide coupling with 2-aminothiophenol and Cbz-L-proline. The benzothiazole ring formed spontaneously without formation of the intermediate aminothioester/amidethiol. However the corresponding reaction with o-phenylenediamine produced the mono-amide, that was first cyclized by refluxing in acetic acid 13 and secondly underwent Nmethylation with MeI in the presence of KOH as a base to form the desired benzimidazole (4b). Chiral HPLC analysis revealed that no racemization occurred during both reaction sequences (>99%).The thiazole ligand precursors were also prepared from simple Cbzprotected L-proline. In this reaction the acid functionality of Lproline was first converted to the corresponding amide precursor in the presence of Boc 2 O, (NH 4 ) 2 CO 3 and pyridine in acetonitrile with a 98% yield. The amide group reacted with Lawesson's reagent and formed thiomide in 70% yield. The Cbz-protected L-proline thioamide 14 cyclized with α-bromoketones in the presence of pyridine in ethanol (Scheme 3) to produce the different types of thiazole ligands. In the case of the ligand with the phenyl substitutent, the reaction was initially performed with phenacyl bromide (R = Ph) using the reflux conditions as described by Pichota. 15 Although the desired product 4c was obtained in 63% yield, some racemization occurred which resulted in the cyclized product of only 90% ee according to chiral HPLC analysis. When the reaction was carried out at room temperature, the product was obtained in 65% yield and >99% ee. Using the same procedure, the ligand precursors 4d and 4e carrying bulky 2-and 1-naphthyl substitutents was prepared with 72% and 65% yield and enantiomeric purity >99% ee.
The ligand precursors 4a-4ewere then subjected to two different methods for Cbz-deprotection. One method was effective for ligand precursors 4b, where the deprotection was carried out in the presence of 10% (Pd/C) in ethanol at10 bar hydrogen pressure in the reaction vessel to give 5b in 98% yield (Scheme4). The second method for the deprotection of ligand precursors 4a, 4c, 4d and 4e was by treatment with 10 equiv of BF 3 .Et 2 O, dimethyl sulphide in dry dicholoromethane to produce various N-H prolinethiazole ligands 5a, 5c, 5d and 5e in good yields (Scheme 5).
Phosphanylation of the pyrrolidine nitrogen atoms of all the ligands 5a-5evia Ar 2 PCl (Ar = Ph or 2-Tolyl) and complex formation with Ir(COD) 2 Cl 2 was achieved. This was followed by counterion exchange with NaBAr F in a one pot reaction to furnish the iridium complexes 6a-6f in moderate to good overall yield in the range of 22-33% (6a and 6b) and 29-52% (6c-6f) (Scheme 6). In the first step N-H prolinethiazole ligands react with di-arylphosphine chloride in the presence of N,N-diisopropylethylamineform the N,P ligands precursors. In the second step the precursors form a complex with Ir(COD) 2 Cl 2 followed by counter anion exchange with NaBArF*H 2 O .
The iridium complexes 6a-6f were evaluated as catalysts for asymmetric hydrogenation of various trisubstituted alkenes (7a-7e, see Table 1 ). The thiazole complex 6c consistently gave superior results (84-99% ee) for most substrates tested compared to the benzothiazole and benzimidazole complexes 6a and 6b. Most notably, hydrogenation of the cyclic alkene substrate 7e catalyzed by the thiazole complex 6c gave the hydrogenated product in 84% ee compared to only 11% and 26% obtained from the complexes 6a and 6b, respectively. On the other hand, ethyl 3-methylcinnamate (7b) gave the Senantiomer of the hydrogenated product in only 47% ee with 6c. This particular substrate also yielded poor results with the complexes 6a and 6b, affording the almost same enantiomer of the product with ee values of 64% and 68% respectively. The enantioselectivity against this particular substrate was improved dramatically when the phosphine substituent was changed from phenyl in complex 5c to the more sterically hindered o-tolyl group in 6d, while the enantioselectivities against other substrates remained the same. An additional advantage of the o-tolyl complexes is that the conversions improve considerably and in most cases, complete conversion (>99%) was observed. Further increasing the steric bulkiness of the thiazole substituent in 6d by replacing the phenyl with 2-naphthyl (6e) and 1-naphthyl (6f) groups resulted in marginal improvement. The complex 6e gave thehighest enantioselectivities with substrates 7a, 7b and 7c while the complex 6f appeared to be more general for this particular set of substrates. The enantioselectivities obtained with the best catalyst 6f (84-97%) compares favorably with more structurally complexes with multiple chiral centers for the same set of substrates. For example, complex2 derived from bicyclic proline gave ee in the range of 83-97% (Ar = Ph; R = Ph) and 76-99% (Ar = o-Tol; R = Ph) 11 . The prolineoxazoline complex 3 (Ar = 2-EtC 6 H 4 ; R = t Bu) developed by Gilbertson 12 gave ee in the range of 68-94% for the same set of substrates. 
Conclusion
In this study we have developed a series of simple proline based heterocyclic N,P-ligands for the asymmetric hydrogenation of olefins. Theseproline based thiazoles ligands efficiently catalyze both functionalized and unfunctionalizedtrisubstituted alkenes. The results, based on theenantioselectivity obtained in this hydrogenation, are among the best compared to what has been reported in literature.
Experimental Section Experimental

Benzothiazole 4a
Cbz-L-proline (0.550 g, 2.2 mmol) was treated with 2-aminothiophenol (2 mmol) and EDC⋅HCl (2 mmol) in CH2Cl2 (5 mL) at room temperature overnight. The mixture was diluted with more CH2Cl2 (20 mL) and washed three times with water (3×20 mL). The combined organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The residue was purified by column chromatography (EtOAc:hexanes 1:4; Rf = 0.35) to give the desired product as yellow oil (0.278 g, 41%). The enantiomeric excess as determined by chiral HPLC was >99% (Chiralcel OD-H 0.46×25 cm; i PrOH:n-hexane 1:9, flow rate 0.5 mL/min; tR(S) = 26.2 min, tR (R) = 32.8 min 
Cbz-L-proline Benzimidazole 4
Cbz-L-proline (1.001 g, 4 mmol) was treated with o-phenylenediamine (0.429 g, 3.8 mmol) and dicyclohexylcarbodiimide (0.873 g, 4 mmol) in CH2Cl2 (10 mL) at room temperature overnight. The dicyclohexylurea precipitate was filtered off and the solvent was removed under reduced pressure. The residue was dissolved in glacial acetic acid (5 mL) and heated at 60 o C for 2 hours. After removal of the solvent, the residue was partitioned in water/CH2Cl2 and extracted with CH2Cl2 (3×20 mL). The combined organic extracts were washed with brine and dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. The residue was purified by column chromatography (EtOAc:hexanes 1:4; Rf = 0.32) to the product give as yellow oil (0.74 g, 58% yield 
Cbz-L-proline N-methyl Benzimidazole 4b
Compound 4 (100 mg, 0.31 mmol, 1 eq) was dissolved in acetone (3 mL). KOH pellets (207 mg) were added followed by MeI (0.12 mL, 1.93 mmol, 6 eq) and reaction solution was stirred for 6.5 hours. Water (10 mL) was added and acetone was evaporated under reduced pressure. The product was extracted with DCM (2 x 15 mL), the combined organic phase was washed with brine (20 mL), dried over Na2SO4 and evaporated. 
Cbz-L-proline thioamide
A mixture of Cbz-L-proline (2.5 g, 10 mmol), Boc2O (2.02 g, 10 mmol,), (NH4)2CO3 (1.06 g 10 mmol) and pyridine (0.16 mL 2 mmol) in acetonitrile (20 mL) was stirred at room temperature overnight. The acetonitrile was removed and the residue partitioned in water/EtOAc and extracted with EtOAc (3×20 mL). The combined organic layers were washed with water, brine and dried over Na2SO4 and the solvent removed under reduced pressure. The crude Cbz-L-prolinamide (assume quantitative yield) was treated with Lawesson's reagent (5 mmol, 2.02 g) in THF (10 mL). After stirring at room temperature overnight, the solvent was removed under vacuum and the residue extracted with EtOAc (3×20 mL). The combined organic layer was dried over Na2SO4 and the solvents removed under reduced pressure. The residue was purified by column chromatography (EtOAc:hexanes7:3; Rf = 0.45) to give a pale yellow oil (2.37 g, 90 % yield 
Phenylthiazole 4c
Cbz-L-proline thioamide (0.801 g, 3.25 mmol) was treated with phenacyl bromide (0.597 g, 3 mmol) and pyridine (1 mL) in CH2Cl2 (10 mL). The mixture was stirred at room temperature overnight. The mixture was extracted with CH2Cl2 (3×20 mL). The organic layer was dried with Na2SO4 and the solvent removed under reduced pressure. The residue was purified by column chromatography (EtOAc:hexanes; 1:4, Rf 0.32) to give yellow oil product (0.776 g, 71% yield). The enantiomeric excess as determined by chiral HPLC was >99% (Chiralcel OD-H 0.46×25 cm; i PrOH:n-hexane 1:9, flow rate 0.5 mL/min; tR(S) = 24.9 min, tR (R) = 32.7 min). 1 
2-Naphthylthiazole 4d
Cbz-L-proline thioamide (0.530 g, 2.2 mmol) was treated with 2-bromoacetylnaphthalene (0.510 g, 2 mmol) and pyridine (0.8 mL) in CH2Cl2 (5 mL). Following the same procedure described for compound 4c above, the desired product was obtained as a yellow oil (0.588 g, 71% yield) after column chromatography (EtOAc:hexanes 1:4; Rf 0.33). The enantiomeric excess as determined by chiral HPLC was 99% (Chiralcel OD-H 0.46×25 cm; i PrOH:n-hexane 1:9, flow rate 0.5 mL/min; tR(S) = 27.6 min, tR (R) = 34.9 min). 1 
1-Naphthylthiazole 4e
Cbz-L-proline thioamide (0.530 g, 2.2 mmol) was treated with 1-bromoacetylnaphthalene (0.512 g, 2 mmol) and pyridine (0.8 mL) in CH2Cl2 (5 mL). Following the same procedure described for compound 4c above, the desired product was obtained as a yellow oil (0.538 g, 65% yield) after column chromatography 
(S)-2-(pyrrolidin-2-yl)benzo[d]thiazole (5a)
Under nitrogen atmosphere Compound 4a (0.15 g, 0.44 mmol, 1 eq) and DCM (4 mL) was added, followed by dimethyl sulfide (0.88 mL) and BF3*OEt2 (0.56 mL, 4.4 mmol, 10 eq). The reaction was stirred at room temperature for 3 hours, after that another portion of dimethyl sulfide (0.71 mL) was added and stirring was continued for 2.5 hours. On completion by TLC, reaction was quenched with aqueous 7% ammonia (10 mL), and then product was extracted with DCM (2 x 20 mL). The combined organic phase was washed with brine (20 ml) and dried over Na2SO4. 
(S)-1-methyl-2-(pyrrolidin-2-yl)-1-H-benzo[d]imidazole (5b)
Compound 4b (67 mg, 0.20 mmol) was dissolved in 99.5 % ethanol (5 mL). Pd/C(10%) (12 mg) was added to the reaction mixture and after applying a 10 bar hydrogen pressure, reaction was stirred for 2 hours. The reaction solution was filtered through a short plug of Celite and solvent was evaporated to afford 40 mg (quant.) of compound 5b that was used in the next step without further purification. 
Complex 6a
In dry toluene (2 mL), compound 5a (63 mg, 0.31 mmol, 1 eq) was added under argon followed by DIPEA (0.16 ml, 0.92 mmol, 3 eq) and reaction was cooled in ice bath. The diphenylphosphine chloride (86 ml, 0.46 mmol, 1.5 eq) was added drop wise and reaction was stirred for 1.5 hours. On completion of reaction by 1 H NMR, solution was filtered through a plug of cotton and solids were washed with dry toluene. The clear solution was evaporated and the residue was co-evaporated with dry toluene (3 x 6 mL) to remove DIPEA. Dry DCM (5 mL) was added to the crude phosphine product under argon followed by [Ir(COD)Cl]2 (104 mg, 0.15 mmol, 0.5 eq) and solution was refluxed for 1.5 hour. After cooling to room temperature, water (5 mL) was added followed by NaBArF*H2O (348 mg, 0.37 mmol, 1.2 eq) and solution was stirred vigorously for 30 minutes. The product was extracted with DCM (2 x 15 mL). The combined organic phase was dried over Na2SO4, evaporated and the residue was purified by chromatography on silica (DCM: 
Complex 6c
According to the synthesis of general procedure 6a, following amounts were used: the compound 5c (47 mg, 0.20 mmol, 1 eq), DIPEA (0.11 mL, 0.63 mmol, 3 eq), diphenylphosphine chloride (57 µL, 0. 
Complex 6d
According to the synthesis of general procedure 6a, following amounts were used: the compound 5c (76 mg, 0.33 mmol, 1 eq), DIPEA (0.17 mL, 0.98 mmol, 3 eq), chlorodi(o-tolyl)phosphine (164 mg, 0.66 mmol, 2 eq) dissolved in toluene (2 mL), [Ir(COD)Cl]2 (111 mg, 0.17 mmol, 0.5 eq) and NaBArF*H2O (465 mg, 0.49 mmol, 1.5 eq). The compound 6d 184 mg (35 %) was isolated as an orange solid. 1 
Complex 6e
According to the synthesis of general procedure 6a, following amounts were used: the compound 5d (73 mg, 0.26 mmol, 1 eq), DIPEA (0.14 mL, 0.80 mmol, 3 eq), chlorodi(o-tolyl)phosphine (129 mg, 0.52 mmol, 2 eq) dissolved in toluene (2 mL), [Ir(COD)Cl]2 (87 mg, 0.13 mmol, 0.5 eq) and NaBArF*H2O (367 mg, 0.39 mmol, 1.5 eq). The compound 6e 125 mg (29 %) was isolated as an orange solid. 1 
